NMPA Approval

Brimonidine Tartrate Eye Drops

Approval Number

H20160425

Registration Date

December 27, 2019

Previous Approval Numbers

H20160425

Drug Information

Generic Name

酒石酸溴莫尼定滴眼液

Dosage Form

眼用制剂

Strength

0.15%

Drug Type

化学药品

Registration Date

December 27, 2019

Expiry Date

December 26, 2024

Company Address

1 N Waukegan Rd, North Chicago, IL 60064 United States of America

Company Address

8301 Mars Drive, Waco, TX 76712 United States of America

Empowering clinical research with data-driven insights and AI-powered tools.